Three undervalued stocks with great potential: Altimmune, Moderna, and Pfizer

From Yahoo Finance: 2025-03-22 06:44:00

Three Motley Fool contributors believe Altimmune (NASDAQ: ALT), Moderna (NASDAQ: MRNA), and Pfizer (NYSE: PFE) are undervalued stocks with great potential. Altimmune is developing a promising weight loss drug with significant market potential. Moderna, known for its mRNA vaccines, has diverse clinical candidates and partnership with Merck for a cancer vaccine. Pfizer’s low valuation and strong growth prospects make it an attractive investment option. Investors may consider these “dirt cheap” stocks for long-term gains.



Read more at Yahoo Finance: Buying These Dirt-Cheap Stocks Could Be a Brilliant Move